title: Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan.
authors.affiliation: Regional Cancer Hospital, Yuzhno-Sakhalinsk, 693010, Russia.
authors.forename: Sergey V
authors.initials: SV
authors.lastname: Silkin
authors.affiliation: Regional Cancer Hospital, Yuzhno-Sakhalinsk, 693010, Russia.
authors.forename: Sergey S
authors.initials: SS
authors.lastname: Startsev
authors.affiliation: Regional Cancer Hospital, Yuzhno-Sakhalinsk, 693010, Russia.
authors.forename: Marina E
authors.initials: ME
authors.lastname: Krasnova
authors.affiliation: Russian Research Centre for Radiology and Surgical Technologies, St.-Petersburg, 197758, Russia.
authors.forename: Grigory A
authors.initials: GA
authors.lastname: Raskin
authors.affiliation: Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia.
authors.forename: Natalia V
authors.initials: NV
authors.lastname: Mitiushkina
authors.affiliation: Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia.|Saint-Petersburg State Pediatric Medical University, St.-Petersburg, 194100, Russia.
authors.forename: Aglaya G
authors.initials: AG
authors.lastname: Iyevleva
authors.affiliation: Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia.|Saint-Petersburg State Pediatric Medical University, St.-Petersburg, 194100, Russia.
authors.forename: Anna P
authors.initials: AP
authors.lastname: Sokolenko
authors.affiliation: Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia. evgeny@imyanitov.spb.ru.|Saint-Petersburg State Pediatric Medical University, St.-Petersburg, 194100, Russia. evgeny@imyanitov.spb.ru.|Medical Faculty, Saint Petersburg State University, Saint-Petersburg, 199034, Russia. evgeny@imyanitov.spb.ru.|I.I. Mechnikov North-Western State Medical University, Saint-Petersburg, 191015, Russia. evgeny@imyanitov.spb.ru.
authors.forename: Evgeny N
authors.initials: EN
authors.lastname: Imyanitov
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018281:Cholangiocarcinoma / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000077146:Irinotecan; D008297:Male; D009154:Mutation; D000077544:Panitumumab; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D000972:Antineoplastic Agents, Phytogenic; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D000077544:Panitumumab; D000077146:Irinotecan; D002166:Camptothecin